Concepedia

Brett Haumann

BH

Statistics

Publications

19

Citations

964

H-Index

18

Active since

2005

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

GlaxoSmithKline (United States)

University of Manchester

University of Gothenburg

University of Wisconsin–Madison

Brett Haumann is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacotherapy, pharmacology, and bronchodilator therapy.

Publications per year

2005–2021

19

Publications

19

Evaluation of an ambulatory system for the quantification of cough frequency in patients with chronic obstructive pulmonary disease

Michael Coyle, D. Barry Keenan, Linda S. Henderson et al. · Cough · 2005 · 113 citations · Full text

, , +15

The Efficacy and Safety of the Novel Long-Acting β2 Agonist Vilanterol in Patients With COPD

Nicola A. Hanania, Gregory Feldman, W. Zachgo et al. · CHEST Journal · 2012 · 105 citations

, , +14

The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol

Jørgen Vestbo, Julie A. Anderson, Robert D. Brook et al. · European Respiratory Journal · 2012 · 92 citations · Full text

, , +15

Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial

William W. Busse, Eugene R. Bleecker, Eric D. Bateman et al. · Thorax · 2011 · 75 citations

, , +17

24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids

Jan Lötvall, Eric D. Bateman, Eugene R. Bleecker et al. · European Respiratory Journal · 2012 · 73 citations · Full text

, , +17

1–5 of 19